
GC62669
CPI-1612
Also known as (2R)-2-[[(2S)-2-(4-cyanophenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide
CPI-1612 is a highly potent, orally active EP300/CBP histone acetyltransferase (HAT) inhibitor with an IC50 of 8·1 nM for EP300 HAT· CPI-1612 has an anticancer activity
ChemicalCAS2374971-81-8MW450.53FormulaC27H26N6O
- CAS number
- 2374971-81-8
- Molecular weight
- 450.53
- Formula
- C27H26N6O
- Solubility
- DMSO : 100 mg/mL (221·96 mM; Need ultrasonic)
- InChIKey
- SEDFZSHSBUXKAC-NIYFSFCBSA-N
- Catalogue number
- GC62669
- Brand
- GLPBIO
Computed properties PubChem CID 146014965 · XLogP 3.6 · TPSA 95.6 Ų · H-bond donors 2
- XLogP
- 3.6
- TPSA
- 95.6 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 8
- Heavy atoms
- 34
SMILES C[C@H](CN[C@H](C1=CC=CC=C1)C(=O)NC2=NC=C(C=C2)C3=CN(N=C3)C)C4=CC=C(C=C4)C#N
Computed descriptors from PubChem (CID 146014965), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il